Focus: Vitestro is a Netherlands-based biotechnology company specializing in blood draw technology, operating at a modest scale of 51-200 employees. The company is developing innovative venipuncture devices to improve phlebotomy procedures.
Profile data last refreshed 2h ago · AI intelligence enriched 2mo ago
Stable — net +4 jobs in 30d
6 added, 2 removed. Backfill posture.
Vitestro is a high-risk, high-upside early-stage medtech play best suited for founders, early-career engineers, or professionals seeking direct impact in a bootstrapped environment.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Core product in clinical validation phase; represents the company's sole disclosed pipeline asset.
Help build intelligence for Vitestro
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Vitestro's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated Phlebotomy Firm Vitestro Eyes 2027 Commercial Launch of Robotic Blood Draw Device - 360Dx
Automated Phlebotomy Firm Vitestro Eyes 2027 Commercial Launch of Robotic Blood Draw Device 360Dx
Medtech company Vitestro pulls US$70M together for autonomous blood draw tech - Mugglehead Investment Magazine
Medtech company Vitestro pulls US$70M together for autonomous blood draw tech Mugglehead Investment Magazine
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles